Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Erythromycin Lactobionate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nexus Receives FDA Approval of Erythromycin Lactobionate for Injection, USP
    Nexus Receives FDA Approval of Erythromycin Lactobionate for Injection, USP

    17 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220217005819/en

    BUSINESSWIRE
    17 Feb 2022
    Share Share
    Nexus Pharms' Generic Erythromycin Lactobionate Receives Approval in the U.S.
    Nexus Pharms' Generic Erythromycin Lactobionate Receives Approval in the U.S.

    14 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215290

    FDA
    14 Feb 2022
    Share Share
    Exela Pharma's Generic Erythromycin Lactobionate Receives Approval In US
    Exela Pharma's Generic Erythromycin Lactobionate Receives Approval In US

    21 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211086

    FDA
    21 Sep 2020
    Share Share
    Prescription med: registration of new generics & biosimilars
    Prescription med: registration of new generics & biosimilars

    05 Jun 2018

    // TGA GOV

    https://www.tga.gov.au/prescription-medicines-registration-new-generic-medicines-and-biosimilar-medicines

    TGA GOV
    05 Jun 2018
    Share Share